$12.49
+0.68
(+5.76%)▲
8.01%
Downside
Day's Volatility :10.13%
Upside
2.31%
59.57%
Downside
52 Weeks Volatility :66.31%
Upside
16.68%
Period | Gh Research Plc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 12.37% | 6.5% | 0.0% |
6 Months | 62.9% | 7.1% | 0.0% |
1 Year | -6.27% | 9.8% | 0.0% |
3 Years | -29.41% | 14.2% | -20.2% |
Market Capitalization | 620.7M |
Book Value | $4.03 |
Earnings Per Share (EPS) | -0.62 |
Wall Street Target Price | 32.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -11.27% |
Return On Equity TTM | -14.31% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -42.0M |
Diluted Eps TTM | -0.62 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.83 |
EPS Estimate Next Year | -1.18 |
EPS Estimate Current Quarter | -0.22 |
EPS Estimate Next Quarter | -0.24 |
What analysts predicted
Upside of 156.2%
Sell
Neutral
Buy
Gh Research Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Gh Research Plc | 3.05% | 62.9% | -6.27% | -29.41% | -39.58% |
![]() Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
![]() Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
![]() Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
![]() Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Gh Research Plc | NA | NA | NA | -0.83 | -0.14 | -0.11 | NA | 4.03 |
![]() Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
![]() Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
![]() Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
![]() Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Gh Research Plc | Buy | $620.7M | -39.58% | NA | 0.0% |
![]() Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
![]() Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Gh Research Plc
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 67.9%
In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 215.9%
Bvf Inc
RA Capital Management, LLC
RTW INVESTMENTS, LLC
FMR Inc
Verition Fund Managegment, LLC
Cormorant Asset Management, LLC
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
Organization | Gh Research Plc |
Employees | 49 |
CEO | Mr. Florian Schonharting M.Sc. (Econ) |
Industry | Services |
Iheartmedia
$12.49
+5.76%
Gigacloud Technology Inc
$12.49
+5.76%
Qurate Retail Inc
$12.49
+5.76%
Madison Square Garden Entertainment Corp
$12.49
+5.76%
Xpel Inc
$12.49
+5.76%
Telecom Argentina S.a.
$12.49
+5.76%
Barrett Business Services Inc
$12.49
+5.76%
Stitch Fix, Inc. (class A Shares)
$12.49
+5.76%
Jack In The Box Inc.
$12.49
+5.76%